# Annovis Bio, Inc.: Form DEF 14A, filed Apr 30, 2025

- Company: [Annovis Bio, Inc.](/companies/anvs.md) (CIK 1477845)
- Form: DEF 14A
- Filed: 2025-04-30
- Accepted by EDGAR: Apr 30, 2025, 17:20 ET
- Period: 2025-06-17
- Accession: 0001104659-25-042679
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1477845/000110465925042679/tm252538d1_def14a.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1477845/000110465925042679/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1477845/000110465925042679/tm252538d1_def14a.htm

Filed Apr 30, 2025.
Source: SEC EDGAR, the filing index for accession 0001104659-25-042679. Last ingested by Listed: Nov 6, 2026, 17:28 ET. No prices; not investment advice.